English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Nanobiotix to Present Preclinical Data on Nanoparticle Radioenhancer NBTXR3 at the AACR Annual Meeting 2017
Mar 07, 2017 15:50 HKT
Imprinting Technology Improves Transistor-Based Biosensors
Feb 28, 2017 18:45 HKT
Uni-Bio Science's Drugs Officially Reimbursed under the National Reimbursement Drug List
Feb 27, 2017 09:10 HKT
Improving DNA-Detecting Transistors
Feb 24, 2017 20:30 HKT
Nanobiotix Appoints Senior Executive from Pharmaceutical Industry, as Chief Operating Officer
Feb 07, 2017 16:30 HKT
NANOBIOTIX: 2016 Review and 2017 Anticipated Milestones
Feb 01, 2017 08:00 HKT
Sino Harbour Establishes New Subsidiary; Proposes to Tap Stem Cell Sector in Guangxi, the PRC
Jan 20, 2017 17:45 HKT
Jacobson Pharma to Acquire Saplingtan, Shiling Oil & Col-gan Tablet; Creating an Expandable Proprietary Medicine Platform
Jan 18, 2017 19:44 HKT
Tongfang Kontafarma Announces Proposed Acquisition of 29% Stake in Korean Pharmaceutical Company Binex
Dec 16, 2016 17:24 HKT
Nanobiotix Reports Positive Phase I/II Preliminary Data on Feasibility and Safety of NBTXR3 in Liver Cancers Trial
Dec 15, 2016 08:00 HKT
Jacobson Pharma Announces Acquisition of 100% Interest in Ho Chai Kung Brand
Dec 13, 2016 09:17 HKT
NovogeneAIT Singapore and the Genome Institute of Singapore Forge Public-Private Partnership to Establish Whole Genome Sequencing Centre in Singapore
Dec 08, 2016 09:00 HKT
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
Dec 01, 2016 11:40 HKT
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3
Nov 29, 2016 08:00 HKT
Jacobson Pharma Announces 2016 Interim Results
Nov 23, 2016 21:27 HKT
Scientists Successfully Create Blood from Skin Cells
Nov 21, 2016 18:00 HKT
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage as In Situ Vaccine for Cancer at the Society for Immunotherapy of Cancer Annual Meeting
Nov 14, 2016 15:20 HKT
The Highs and Lows of Regenerative Medicine
Nov 09, 2016 07:30 HKT
Nanobiotix' Partner PharmaEngine Has Launched a New NBTXR3 Clinical Trial in Head and Neck Cancers in Asia
Nov 07, 2016 17:00 HKT
Shining Light on Disease
Nov 05, 2016 07:20 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: